Birth Defects after Vaccine
Pedro L Moro 1, Janet Cragan 2, Paige Lewis 1, Lakshmi Sukumaran 1
Affiliations expand
- PMID: 28762675
- PMCID: PMC6528469
- DOI: 10.1002/bdr2.23622
Free PMC article
Abstract
Background: Major birth defects are important infant outcomes that have not been well studied in the postmarketing surveillance of vaccines given to pregnant women. We assessed the presence of major birth defects following vaccination in the Vaccine Adverse Event Reporting System (VAERS), a national spontaneous reporting system used to monitor the safety of vaccines in the United States.
Methods: We searched VAERS for reports of major birth defects during January 1, 1990, through December 31, 2014. We excluded birth defects from vaccines that had been studied in pregnancy registries or other epidemiological studies (e.g., human papilloma virus, varicella, measles/mumps/rubella, and anthrax vaccines). Birth defects were categorized into trimester of vaccination and classified based on the organs and/or systems affected. If several birth defects affecting different systems were described, we classified those as multiple body systems. Empirical Bayesian data mining was used to assess for disproportionate reporting.
Results: We identified 50 reports of major birth defects; in 28 reports, the vaccine was given during the first trimester; 25 were reports with single vaccines administered. Birth defects accounted for 0.03% of all reports received by VAERS during the study period and 3.2% of pregnancy reports; reported defects affected predominately the musculoskeletal (N = 10) or nervous (N = 10) systems. No unusual clusters or specific birth defects were identified.
Conclusion: This review of the VAERS database found that major birth defects were infrequently reported, with no particular condition reported disproportionally. Birth defects after routine maternal vaccination will continue to be monitored in VAERS for signals to prompt future studies. Birth Defects Research 109:1057-1062, 2017. © 2017 Wiley Periodicals, Inc.
Keywords: birth defects; epidemiology; surveillance; vaccine; vaccine safety.
© 2017 Wiley Periodicals, Inc.
Conflict of interest statement
Conflict of interest: None of the authors have a conflict of interest.
Similar articles
- Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)–United States, 1991-2001.Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS, Braun MM, Chen RT.MMWR Surveill Summ. 2003 Jan 24;52(1):1-24.PMID: 12825543
- Assessing the safety of hepatitis B vaccination during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 1990-2016.Moro PL, Zheteyeva Y, Barash F, Lewis P, Cano M.Vaccine. 2018 Jan 2;36(1):50-54. doi: 10.1016/j.vaccine.2017.11.039. Epub 2017 Nov 27.PMID: 29174107 Free PMC article.
- Data mining for prospective early detection of safety signals in the Vaccine Adverse Event Reporting System (VAERS): a case study of febrile seizures after a 2010-2011 seasonal influenza virus vaccine.Martin D, Menschik D, Bryant-Genevier M, Ball R.Drug Saf. 2013 Jul;36(7):547-56. doi: 10.1007/s40264-013-0051-9.PMID: 23657824
- Adverse events following quadrivalent meningococcal CRM-conjugate vaccine (Menveo®) reported to the Vaccine Adverse Event Reporting system (VAERS), 2010-2015.Myers TR, McNeil MM, Ng CS, Li R, Lewis PW, Cano MV.Vaccine. 2017 Mar 27;35(14):1758-1763. doi: 10.1016/j.vaccine.2017.02.030. Epub 2017 Mar 3.PMID: 28262331 Free PMC article.
- Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006.Chang S, Ball R, Braun MM.Vaccine. 2008 May 2;26(19):2428-32. doi: 10.1016/j.vaccine.2008.02.052. Epub 2008 Mar 17.PMID: 18406499 Review.
Cited by 2 articles
- Maternal vaccination: a review of current evidence and recommendations.Etti M, Calvert A, Galiza E, Lim S, Khalil A, Le Doare K, Heath PT.Am J Obstet Gynecol. 2022 Apr;226(4):459-474. doi: 10.1016/j.ajog.2021.10.041. Epub 2021 Nov 11.PMID: 34774821 Free PMC article. Review.
- Updates on Vaccine Safety and Post-Licensure Surveillance for Adverse Events Following Immunization in South Korea, 2005-2017.Yoon D, Kim JH, Lee H, Shin JY.Yonsei Med J. 2020 Jul;61(7):623-630. doi: 10.3349/ymj.2020.61.7.623.PMID: 32608206 Free PMC article.
Leave a comment